HealthCCSng vs Reveal LINQ Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

HealthCCSng

by Nano-X AI

Reveal LINQ Insertable Cardiac Monitor

by Medtronic

AI Verdict

HealthCCSng utilizes AI to analyze routine CT scans for the detection and quantification of coronary artery calcification, focusing on assessing the risk of coronary artery disease. Conversely, the Reveal LINQ Insertable Cardiac Monitor is an implantable device that employs AI algorithms for long-term, continuous ECG monitoring to diagnose cardiac arrhythmias and reduce false alerts. While both are cardiology-focused AI solutions, they address different aspects of cardiac health: one for structural disease risk assessment via imaging, and the other for electrical rhythm disorder detection through continuous monitoring.

Choose HealthCCSng if…

Choose HealthCCSng if you need to proactively assess a patient's risk of coronary artery disease using existing or routine chest CT scans. This AI-powered solution is ideal for automatically detecting and quantifying coronary artery calcification, providing a numerical calcium score and visual evidence to guide early intervention strategies. It streamlines the workflow by integrating with PACS and EMR systems to deliver results without human intervention.

View HealthCCSng →

Choose Reveal LINQ Insertable Cardiac Monitor if…

Choose the Reveal LINQ Insertable Cardiac Monitor if you require long-term, continuous monitoring to diagnose intermittent or elusive cardiac arrhythmias such as atrial fibrillation or unexplained syncope. This implantable device offers extended battery life and uses AccuRhythm™ AI algorithms to significantly reduce false alerts, ensuring a higher diagnostic yield for conditions that may not be captured during short-term monitoring. It's best suited for patients needing prolonged, accurate heart rhythm surveillance.

View Reveal LINQ Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	HealthCCSng	Reveal LINQ Insertable Cardiac Monitor
Pricing	Not publicly available	Contact vendor
Deployment	Cloud-based, integrates with PACS and EMR systems	Implantable device with data transmitted to a cloud-based platform (CareLink™ network) via patient smartphone app or home communicator.
BAA Available	Unknown	Yes AI-estimated
FDA Status	Yes AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

HealthCCSng

HealthCCSng (Tool A) offers a highly streamlined and efficient user experience by seamlessly integrating with existing PACS and EMR systems and providing an automated workflow for results without human intervention. This passive analysis of routine CT scans minimizes additional steps for clinicians. In contrast, the Reveal LINQ ICM (Tool B) is an implantable device that requires patient involvement for data transmission via a smartphone app or home communicator, adding a layer of patient-side interaction to the overall workflow.

Clinical Value

Reveal LINQ Insertable Cardiac Monitor

While both tools offer significant clinical value, the Reveal LINQ ICM (Tool B) with AccuRhythm AI algorithms provides a direct and quantifiable improvement in diagnostic accuracy by significantly reducing false atrial fibrillation and pause alerts. This reduction in false positives saves clinicians substantial review time and enhances diagnostic confidence for intermittent arrhythmias. HealthCCSng (Tool A) provides valuable risk stratification for CAD from routine scans, but Tool B's AI directly refines the quality and actionability of diagnostic data.

Pricing & Value

Tie

Neither HealthCCSng (Tool A) nor Reveal LINQ ICM (Tool B) has publicly disclosed pricing information. While some third-party sources mention potential costs for Tool B, these are not official and cannot be definitively compared. Therefore, without transparent pricing, it is impossible to assess their relative value propositions.

Enterprise Readiness

Reveal LINQ Insertable Cardiac Monitor

Medtronic (Tool B's company) is the world's largest medical device company, operating in over 150 countries with extensive experience in deploying and supporting complex medical technologies within healthcare systems globally. This established scale, robust infrastructure, and long history provide a stronger foundation for enterprise readiness, including comprehensive support and security. Although HealthCCSng (Tool A) is FDA-cleared, HIPAA compliant, and integrates with PACS/EMR, Nano-X AI is a newer company with a less established global enterprise footprint.

Innovation

Reveal LINQ Insertable Cardiac Monitor

Both tools demonstrate innovation, but the Reveal LINQ ICM (Tool B) stands out for its AccuRhythm AI algorithms that directly address a critical and long-standing challenge in cardiac monitoring: false alerts. By significantly reducing false positives (e.g., up to 89.5% for AF alerts), this AI innovation drastically improves diagnostic efficiency and clinician workflow. HealthCCSng (Tool A) innovates by opportunistically leveraging existing CT scans for CAC scoring, but Tool B's AI provides a more targeted and impactful refinement to an established diagnostic technology.

Support & Docs

Reveal LINQ Insertable Cardiac Monitor

Medtronic (Tool B's company), as a global leader in medical technology, offers extensive support and documentation for its products, including 24-hour technical support for its CareLink platform and comprehensive online resources. For HealthCCSng (Tool A), no specific details regarding support or documentation were provided in the available information. Medtronic's established infrastructure ensures robust and readily available assistance for clinicians and patients.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	HealthCCSng	Reveal LINQ Insertable Cardiac Monitor
Name	HealthCCSng	Reveal LINQ Insertable Cardiac Monitor
Company	Nano-X AI	Medtronic
Description	FDA-cleared AI-powered solution that analyzes routine CT scans to automatically detect and quantify coronary artery calcification (CAC), identifying patients at risk of coronary artery disease.	The Medtronic LINQ IIu2122 Insertable Cardiac Monitor (ICM) with AccuRhythmu2122 AI algorithms provides long-term, accurate heart monitoring by using deep learning AI to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation and syncope.
Primary Function	Detects and quantifies coronary artery calcification (CAC) from CT scans.	Long-term, accurate heart monitoring for conditions like atrial fibrillation and syncope.
Key AI Feature	Automatically detects and quantifies coronary artery calcification (CAC)	AccuRhythmu2122 AI algorithms for reduced false alerts (AF and Pause)
Specialties	Cardiology, Radiology	Cardiology, Pediatrics

Videos

Demos, reviews, and walkthroughs featuring HealthCCSng and Reveal LINQ Insertable Cardiac Monitor.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of HealthCCSng and the Reveal LINQ Insertable Cardiac Monitor?

HealthCCSng is an AI-powered solution that analyzes routine CT scans to automatically detect and quantify coronary artery calcification (CAC), identifying patients at risk of coronary artery disease. The Reveal LINQ Insertable Cardiac Monitor provides long-term, accurate heart monitoring to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation and syncope.

How do these tools acquire and process patient data?

HealthCCSng analyzes non-contrast, non-ECG gated chest CT scans to automatically detect and quantify coronary artery calcification. The Reveal LINQ ICM is an implantable device that provides continuous, long-term subcutaneous ECG monitoring, with data transmitted to a cloud-based platform via a patient smartphone app or home communicator.

What is the role of AI in each of these solutions?

HealthCCSng uses AI to automatically detect and quantify coronary artery calcification from CT scans, categorizing studies and generating a numerical calcium score. The Reveal LINQ ICM utilizes AccuRhythm AI algorithms to reduce false alerts for atrial fibrillation and pause, thereby enhancing diagnostic yield.

What are the key differences in patient interaction and invasiveness between HealthCCSng and the Reveal LINQ ICM?

HealthCCSng is a non-invasive, cloud-based solution that analyzes existing routine CT scans without direct patient interaction beyond the initial scan. The Reveal LINQ ICM is an implantable device requiring a minor surgical procedure for insertion, providing continuous monitoring over several years.

How do these tools integrate into a physician's workflow and existing systems?

HealthCCSng is cloud-based and integrates seamlessly with PACS and EMR systems, providing an automated workflow for results without human intervention. The Reveal LINQ ICM transmits data to the cloud-based CareLink network via a patient smartphone app or home communicator, and offers remote programming capabilities.

For which medical specialties are these tools primarily intended?

HealthCCSng is primarily intended for Cardiology and Radiology specialties. The Reveal LINQ Insertable Cardiac Monitor is designed for Cardiology and Pediatrics.